Could Another Acquisition Be on the Horizon for Tilray?
The company's merger with Aphria closed in May, but investors shouldn't rule out another one in the near future.
Cannabis company Tilray (NASDAQ:TLRY) is hoping to reach $4 billion in annual revenue by 2024. For a company that is currently at a run rate of less than $700 million -- it has a long way to go in reaching that target.
© 420 Intel